Market Overview

UPDATE: Jefferies Raises PT on CME Group on 1Q13 Exchange Preview

Related CME
A Huge Rally Is Occurring Right Now In...Electronic Trading Stocks?
CME Group, China Securities Index Co. Sign Agreement to Develop Commodity Indexes

In a report published Monday, Jefferies analyst Daniel T. Fannon reiterated a Buy rating on CME Group (NASDAQ: CME), and raised the price target from $65.00 to $69.00.

In the report, Fannon noted, “We have lowered our 1Q13 EPS expectations for the traditional equity exchanges, while our numbers for the derivatives exchanges remain relatively unchanged. This mirrors the state of general industry trends, where the outlook for derivatives volume growth is much stronger than equity volume growth. CME and ICE remain our favorite ideas in the group.”

CME Group closed on Friday at $60.48.

Latest Ratings for CME

Oct 2015Keefe Bruyette & WoodsMaintainsMarket Perform
Sep 2015JP MorganMaintainsNeutral
Aug 2015BarclaysMaintainsEqualweight

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings


Related Articles (CME)

Get Benzinga's Newsletters